摘要
Milette DIVINAGRACIA TIO 医师
皮肤科医师
Safer approach to non-surgical rhinoplasty
Objectives: 1. To compare different kinds of nonsurgical rhinoplasty.
2. To share experiences using different products and methods of injection (needle vs cannula)
3. To recommend a safer approach based on findings and differentiation of techniques.
Introduction: Nonsurgical nasal augmentation is already a popular approach in Asia in which it is marketed as safer and less downtime. It can be done thru either using dermal filler, PDO/PCL threads or combination, with and without neurotoxin. However, there are already studies stating that half of the cases of blindness associated with injecting dermal filler according to location is at the nasal area. The goal of this study is to share experiences using different products and methods of injection (needle versus cannula) for lesser risk nonsurgical augmentation.
Materials / method: A retrospective analysis using patient's records before and after photos in 380 cases from 2019 to 2023. Patients' age were 18 to 50 years old. There were 50 patients used filler alone injected by a sharp needle. Injected with cannula were 100 while
210 combinations of fillers plus PDO/PCL threads. Excluded were patients who had a history of previous rhinoplasty and lost to follow up A routine feedback satisfaction scores were asked through clinical follow up, social media, personal messages after 2- week and 6-month-period.Consent were done for the procedure and photos.
Results: For the total number of patients, there was a 97% interviewed upon follow up with satisfactory results. Only one case was observed to have upward bulge at the angular artery immediately after the injection of filler using a gauge 27 needle but hyaluronidase was immediately used.
Conclusion: Lesser risk in nonsurgical rhinoplasty can be achieved by choosing cannula over sharp needles. By combining with more threads, it can lessen the need of more dermal filler product. Using ice packs before injection can help in narrowing the vessels before injection. Overall, there is a significant patient’s aesthetic satisfaction six months after the procedure.
披露 - Milette DIVINAGRACIA TIO
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2024年 3月 22日 - Recorded during IMCAS World Congress 2024